• HEALTHCARE PROFESSIONALS
  • CONTACT US
logo
  • About
    • Leadership Team
    • Board of Directors
    • Medical Advisory Board
    • Corporate Advisors
    • Contact us
  • Research
    • Alicaforsen
    • Renzapride
    • Publications
    • Glossary
  • Investors
  • News
  • Search
  • HEALTHCARE PROFESSIONALS
  • CONTACT US

Clinical trial: Renzapride therapy for constipation-predominant irritable bowel syndrome– multicenter, randomized, placebo-controlled, double-blind study in primary healthcare setting

George AM, Meyers NL & Hickling RI. (2008) Aliment Pharmacol Ther; 27:…


by Kirsti

Pilot study of the efficacy of renzapride on gastrointestinal motility and symptoms in patients with constipation-predominant irritable bowel syndrome

Tack, J., Middleton, S. J., Horne, M. C., Piessevaux, H., Bloor, J. S.,…


by Kirsti

Effect of renzapride on transit in constipation-predominant irritable bowel syndrome

Camilleri M, McKinzie S, Fox J, Foxx-Orenstein A, Burton D & Thomforde,…


by Kirsti

Privacy Preference Center

Privacy Preferences

Privacy Policy